MSLP:OTCPK (USA)

MusclePharm Corp

$ 0.55 -0.08 (-12.7%)
On watch
Volume: 6,346 Avg Vol (1m): 12,044
Market Cap $: 8.42 Mil Enterprise Value $: 25.99 Mil
P/E (TTM): 0.00 P/B: 0.00
Earnings Power Value -2.39
Net Current Asset Value -1.27
Tangible Book -1.21
Projected FCF -5.25
Median P/S Value 1.97
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 3/10

Current vs industry vs history
Cash-to-Debt 0.09
Equity-to-Asset -0.62
Debt-to-Equity -1.11
Debt-to-EBITDA -8.20
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.90
DISTRESS
GREY
SAFE
Beneish M-Score -3.35
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -44.92%
WACC 15.52%

Profitability & Growth : 2/10

Current vs industry vs history
Operating Margin % -1.69
Net Margin % -7.41
ROA % -25.24
ROC (Joel Greenblatt) % -88.28
3-Year Total Revenue Growth Rate -16.80
N/A
3-Year Total EBITDA Growth Rate 19.30
3-Year EPS w/o NRI Growth Rate 14.20

» MSLP's 30-Y Financials

Financials (Next Earnings Date: )

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with OTCPK:MSLP

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Consumer Packaged Goods » Packaged Foods    NAICS : 311999    SIC : 2099
Compare TSXV:PKT OVSE:K2LT LSE:PVG HKSE:08108 XCNQ:PRL TSE:3041 TSE:7578 NAS:XSPA TSE:2437 XSAT:HOME B OSTO:UTG OTCPK:GTVI OTCPK:GRNE WAR:HLD ASX:MFD HKSE:00079 HKSE:08296 TSE:9439 TSE:2417 ROCO:4804
Traded in other countries
Address 4400 Vanowen Street, Burbank, CA, USA, 91505
MusclePharm Corporation is a US-based performance lifestyle company. It develops, manufactures, markets and distributes branded nutritional supplements. It offers various types of powders, capsules, tablets and gels. Geographically, the firm has its business presence across the region of US and in the international market of which the US accounts for the majority of revenue. The company's MusclePharm Hybrid series products include Assault, Amino1, and Combat Protein Powder; and MusclePharm Core products comprise BCAA 3:1:2, CLA Core, and Fish Oil. The group sells its products to various fitness enthusiasts, such as professional, combat sport, weight training, bodybuilding, running, and various team and individual sports, as well as individuals who lead an active lifestyle.

Ratios

Current vs industry vs history
PS Ratio 0.08
EV-to-EBIT -7.44
EV-to-EBITDA -11.04
EV-to-Revenue 0.24
Current Ratio 0.93
Quick Ratio 0.67
Days Inventory 35.42
Days Sales Outstanding 55.59
Days Payable 103.20

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -3.70

Valuation & Return

Current vs industry vs history
Price-to-Median-PS-Value 0.28
Earnings Yield (Joel Greenblatt) % -13.45

More Statistics

Revenue (TTM) (Mil) $ 106.6
EPS (TTM) $ -0.54
Beta 2.12
Volatility % 94.73
52-Week Range $ 0.3 - 1.43
Shares Outstanding (Mil) 15.31

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 3
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y